Kinetic studies of mutant human adenylosuccinase. 1989

B A Barshop, and A S Alberts, and H E Gruber
Department of Pediatrics, University of California San Diego, La Jolla 92093-01613.

Residual adenylosuccinase activity was studied in cultured lymphoblasts from a pair of siblings with infantile autism who have been previously shown to have a deficiency of the enzyme. The rates and distribution of de novo purine synthesis by intact cells were nearly normal. There was no evidence of inhibitory activity in the lysates of the mutant cells. The optimal pH was indistinguishable from that in control cells. The apparent Km in the two mutant cells lines is not significantly different from normal, but the mutants displayed markedly decreased maximum steady-state velocities. Residual activities in mutant cells show decreased thermal stability, suggesting that there is a structural mutation of the adenylosuccinase in the mutant cells.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008190 Lyases A class of enzymes that catalyze the cleavage of C-C, C-O, and C-N, and other bonds by other means than by hydrolysis or oxidation. (Enzyme Nomenclature, 1992) EC 4. Desmolase,Desmolases,Lyase
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011687 Purines A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006358 Hot Temperature Presence of warmth or heat or a temperature notably higher than an accustomed norm. Heat,Hot Temperatures,Temperature, Hot,Temperatures, Hot

Related Publications

B A Barshop, and A S Alberts, and H E Gruber
July 1968, Canadian journal of biochemistry,
B A Barshop, and A S Alberts, and H E Gruber
January 1981, Muscle & nerve,
B A Barshop, and A S Alberts, and H E Gruber
May 1964, Canadian journal of biochemistry,
B A Barshop, and A S Alberts, and H E Gruber
January 1993, Journal of inherited metabolic disease,
B A Barshop, and A S Alberts, and H E Gruber
April 1974, Blood,
B A Barshop, and A S Alberts, and H E Gruber
January 1986, Advances in experimental medicine and biology,
B A Barshop, and A S Alberts, and H E Gruber
January 1998, Ryoikibetsu shokogun shirizu,
B A Barshop, and A S Alberts, and H E Gruber
November 1995, Biochemistry,
B A Barshop, and A S Alberts, and H E Gruber
May 1960, Genetics,
B A Barshop, and A S Alberts, and H E Gruber
August 2004, Biochemistry,
Copied contents to your clipboard!